01 5ABBVIE
01 58648037
01 5Y
01 5Y
01 52032-01-19
Patent Expiration Date : 2032-01-19
US Patent Number : 8648037
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215110
Patent Use Code : U-3238
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-19
Patent Expiration Date : 2032-01-19
US Patent Number : 8648037
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209394
Patent Use Code : U-4206
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-19
Patent Expiration Date : 2032-01-19
US Patent Number : 8648037
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215110
Patent Use Code : U-4206
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-19
Patent Expiration Date : 2032-01-19
US Patent Number : 8648037
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209394
Patent Use Code : U-3237
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-19
Patent Expiration Date : 2032-01-19
US Patent Number : 8648037
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209394
Patent Use Code : U-2141
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-19
